• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[生物利用度及其影响因素]

[Bioavailability and factors influencing its rate].

作者信息

Vraníková Barbora, Gajdziok Jan

出版信息

Ceska Slov Farm. 2015 Spring;64(1-2):7-13.

PMID:26084643
Abstract

Bioavailability can be defined as the rate and range of active ingredient absorption, when it becomes available in the systemic circulation or at the desired site of drug action, respectively. Drug bioavailability after oral administration is affected by anumber of different factors, including physicochemical properties of the drug, physiological aspects, the type of dosage form, food intake, biorhythms, and intra- and interindividual variability of the human population. This article is the first from the series dealing with the bioavailability and methods leading to its improvement. The aim of the present paper is to provide an overview of aspects influencing the rate of bioavailability after oral administration of the active ingredient. Subsequentarticles will provide detailed descriptions of methods used for dug bioavailability improvement, which are here only summarized.

摘要

生物利用度可分别定义为活性成分在体循环中或在药物作用的预期部位可用时的吸收速率和范围。口服给药后的药物生物利用度受多种不同因素影响,包括药物的物理化学性质、生理因素、剂型类型、食物摄入、生物节律以及人群的个体内和个体间变异性。本文是关于生物利用度及其改善方法系列文章中的第一篇。本文的目的是概述影响活性成分口服给药后生物利用度速率的各个方面。后续文章将详细描述用于改善药物生物利用度的方法,本文仅作总结。

相似文献

1
[Bioavailability and factors influencing its rate].[生物利用度及其影响因素]
Ceska Slov Farm. 2015 Spring;64(1-2):7-13.
2
Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.基于脂质的系统作为提高难溶性药物生物利用度的一种有前景的方法。
Acta Pharm. 2013 Dec;63(4):427-45. doi: 10.2478/acph-2013-0040.
3
Diverse approaches for the enhancement of oral drug bioavailability.多种方法提高口服药物生物利用度。
Biopharm Drug Dispos. 2011 May;32(4):185-209. doi: 10.1002/bdd.750. Epub 2011 Apr 7.
4
[The bioavailability of orally administered drugs with special regard to the liver as a filter for foreign matter].[口服给药的生物利用度,特别关注肝脏作为外来物质的过滤器]
Schweiz Med Wochenschr. 1980 Mar 8;110(10):354-62.
5
Drug dissolution: significance of physicochemical properties and physiological conditions.药物溶解:物理化学性质和生理条件的重要性
Drug Discov Today. 2013 Dec;18(23-24):1173-84. doi: 10.1016/j.drudis.2013.08.013. Epub 2013 Sep 13.
6
Pharmaceutical cocrystals: a novel approach for oral bioavailability enhancement of drugs.药物共晶:提高药物口服生物利用度的新方法。
Crit Rev Ther Drug Carrier Syst. 2012;29(3):183-218. doi: 10.1615/critrevtherdrugcarriersyst.v29.i3.10.
7
Mathematical Models to Explore Potential Effects of Supersaturation and Precipitation on Oral Bioavailability of Poorly Soluble Drugs.探索过饱和和沉淀对难溶性药物口服生物利用度潜在影响的数学模型
AAPS J. 2015 Jul;17(4):902-17. doi: 10.1208/s12248-015-9748-2. Epub 2015 Apr 8.
8
Drivers of absolute systemic bioavailability after oral pulmonary inhalation in humans.经口肺部吸入后在人体中的绝对系统生物利用度的驱动因素。
Eur J Pharm Biopharm. 2021 Jul;164:36-53. doi: 10.1016/j.ejpb.2021.04.014. Epub 2021 Apr 23.
9
Bioavailability Enhancement of Poorly Soluble Drugs: The Holy Grail in Pharma Industry.提高难溶性药物生物利用度:制药行业的圣杯。
Curr Pharm Des. 2019;25(9):987-1020. doi: 10.2174/1381612825666190130110653.
10
Impact of Food and Drink Administration Vehicles on Paediatric Formulation Performance: Part 1-Effects on Solubility of Poorly Soluble Drugs.食品和饮料管理车辆对儿科配方性能的影响:第 1 部分-对难溶性药物溶解度的影响。
AAPS PharmSciTech. 2020 Jun 26;21(5):177. doi: 10.1208/s12249-020-01722-z.

引用本文的文献

1
and Pharmacokinetic Studies of a Dual Topoisomerase I/II Inhibitor.一种双拓扑异构酶I/II抑制剂的药代动力学研究
ACS Pharmacol Transl Sci. 2025 Mar 12;8(4):1050-1071. doi: 10.1021/acsptsci.4c00596. eCollection 2025 Apr 11.
2
High-dose naloxone formulations are not as essential as we thought.高剂量纳洛酮制剂并不像我们想象的那么重要。
Harm Reduct J. 2024 May 13;21(1):93. doi: 10.1186/s12954-024-00994-z.
3
Pharmacokinetics and relative bioavailability study of two cefquinome sulfate intramammary infusions in cow milk.两种硫酸头孢喹肟乳房内注入剂在牛奶中的药代动力学及相对生物利用度研究
Front Vet Sci. 2024 Mar 11;11:1384076. doi: 10.3389/fvets.2024.1384076. eCollection 2024.
4
In silico toxicity and immunological interactions of components of calcium silicate-based and epoxy resin-based endodontic sealers.基于硅酸钙和环氧树脂的根管封闭剂成分的计算机毒性和免疫相互作用。
Clin Oral Investig. 2024 Feb 14;28(2):148. doi: 10.1007/s00784-024-05548-y.
5
Efficacy of the intranasal application of azaperone for sedation in weaned piglets.氮哌酮鼻内给药对断奶仔猪镇静的效果。
Vet Med (Praha). 2023 Apr 26;68(4):145-151. doi: 10.17221/21/2023-VETMED. eCollection 2023 Apr.
6
Therapeutic Applications of Curcumin in Diabetes: A Review and Perspective.姜黄素在糖尿病治疗中的应用:综述与展望。
Biomed Res Int. 2022 Feb 2;2022:1375892. doi: 10.1155/2022/1375892. eCollection 2022.